Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Paralysis
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Paralysis
Description
A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45) MeSH
Hierarchy View
Subtype Terms (9)
Facial Paralysis
6 approved drugs
Gastroparesis
44 drugs (26 approved, 18 experimental)
Hemiplegia
7 drugs (5 approved, 2 experimental)
Ophthalmoplegia
2 drugs (1 approved, 1 experimental)
Paraplegia
3 drugs (1 approved, 2 experimental)
Pseudobulbar Palsy
2 approved drugs
Quadriplegia
7 drugs (4 approved, 3 experimental)
Respiratory Paralysis
2 approved drugs
Vocal Cord Paralysis
4 drugs (1 approved, 3 experimental)
Phase 4 Indicated Drugs (5)
Phase 3 Indicated Drugs (1)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (19)
Organization Involved with Phase 2 Indications (32)
Organization Involved with Phase 1 Indications (17)
Organization Involved with Other Experimental Indications (19)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
